Logo XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. bone disease
Show results for
Products
Services
Applications

Companies

News
Articles
Magazines
Downloads
Videos

Refine by
Date

  • Older

Bone Disease Articles & Analysis

30 news found

Creative Diagnostics Introduces ELISA Kit Development Services to Support IVD Research

Creative Diagnostics Introduces ELISA Kit Development Services to Support IVD Research

With expertise in antibody generation and immunoassay development, Creative Diagnostics can generate various diagnostic antibodies covering a wide range of diseases, including infectious diseases, cardiovascular diseases, cancer and bone diseases, especially osteoporosis. In addition, Creative Diagnostics ...

ByCreative Diagnostics


The Importance of Diagnosing Osteoporosis in Women

The Importance of Diagnosing Osteoporosis in Women

A widespread yet underrated medical condition, Osteoporosis is a bone disease seldom paid importance to in today’s world. In this condition, the bones are porous, meaning they lack density and contain holes – unlike the regular bone structure. ...

ByBeamMed Inc.


Osteoporosis in Older Patients Easy Assessment Easy Assessment of Osteoporosis in Older Patients

Osteoporosis in Older Patients Easy Assessment Easy Assessment of Osteoporosis in Older Patients

According to the National Osteoporosis Foundation (NOF), about 54 million Americans suffer from osteoporosis, presenting low bone mass, and suffering from brittle-bone related injuries, such as fractures, and broken bones. In fact, the disease is responsible for “two million broken bones and $19 billion in ...

ByBeamMed Inc.


VeriSIM Life Named “Predictive Analytics Solution of the Year” by BioTech Breakthrough

VeriSIM Life Named “Predictive Analytics Solution of the Year” by BioTech Breakthrough

The company is also co-developing new drugs with Mayo Clinic in key disease areas, including oncology, hematology, bone/joint disorders, and neurological diseases. ...

ByVeriSIM Life


PharmAbcine Signs MoU with FutureChem to Explore Possibilities of Developing Novel Radiopharmaceuticals

PharmAbcine Signs MoU with FutureChem to Explore Possibilities of Developing Novel Radiopharmaceuticals

Radiopharmaceuticals are radioactive agents that are utilized for the diagnosis of infection, vessel-related diseases, bone/bone marrow diseases, tumors, and other diseases in heart, lung, kidney, liver etc. ...

ByPharmAbcine Inc.


Factors of Lighting in Broiler Production

Factors of Lighting in Broiler Production

Therefore, broiler breeders often adopt advanced light control systems to appropriately strengthen the light to extend exercise time, thereby reducing bone diseases. Light Duration Studies have shown that broilers grow better in an environment with suitable continuous lights. ...

ByShenZhen Hontech-Wins Electronics Co.,LTD


VeriSIM Life Enters into Collaboration Agreement with Mayo Clinic to Jointly Advance Drug Discovery and Development Programs

VeriSIM Life Enters into Collaboration Agreement with Mayo Clinic to Jointly Advance Drug Discovery and Development Programs

VeriSIM will engage Mayo Clinic physician researchers in key disease areas including oncology, hematology, bone/joint-disorders, and neurological diseases. ...

ByVeriSIM Life


Former Professional Baseball Player Pain-Free after Knee Surgery with Active Robot Technology Available at INOV8 Surgical

Former Professional Baseball Player Pain-Free after Knee Surgery with Active Robot Technology Available at INOV8 Surgical

” Based upon the severity of his diseased knee joint, Dr. Kreuzer told Art he was a candidate for a knee replacement and could benefit from having his procedure performed with an innovative technology, the TSolution One Total Knee Application, which features an active robot. ...

ByThink Surgical Inc.


Rocket Pharmaceuticals Presents Positive Top-line Data from Severe Leukocyte Adhesion Deficiency-I Program at the 25th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)

Rocket Pharmaceuticals Presents Positive Top-line Data from Severe Leukocyte Adhesion Deficiency-I Program at the 25th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)

Moreover, they point to the great possibilities lentiviral-based gene therapies can offer for patients with devastating diseases,” said Gaurav Shah, M.D., Chief Executive Officer of Rocket Pharma. ...

ByRocket Pharmaceuticals, Inc.


KLISBio to present SILKBridge for peripheral nerve repair and its innovative silk-based tissue-engineered technology platform at 2022 Bio€quity Europe

KLISBio to present SILKBridge for peripheral nerve repair and its innovative silk-based tissue-engineered technology platform at 2022 Bio€quity Europe

KLISBio is targeting a variety of clinical indications, such as peripheral nerve injuries, peripheral vascular diseases, bone defects, tendon tears and situations where a sustained drug release is needed. ...

ByKLISBio


Iktos and Teijin Pharma to Co-Develop New Technology for Small Molecule Drug Discovery

Iktos and Teijin Pharma to Co-Develop New Technology for Small Molecule Drug Discovery

Based on the recent drastic demographic change and increased health consciousness, Teijin Pharma is committed to providing healthcare solutions in the priority fields of bone, joint, rehabilitation, neurology, respiratory, cardiovascular and metabolic diseases. ...

ByIktos


KLISBio to share its leading-edge silk-based technology platform at 2022 AAOS Annual Meeting

KLISBio to share its leading-edge silk-based technology platform at 2022 AAOS Annual Meeting

KLISBio is focused on healing and regenerating human body tissues by developing innovative solutions that solve prominent, unmet clinical needs through a silk-based multidisciplinary technology platform able to generate products and solutions for a variety of clinical indications, such as peripheral nerve injuries, peripheral vascular diseases, bone defects, ...

ByKLISBio


KLISBio to disclose state-of-the-art tissue-engineered technology platform at 2022 CG Musculoskeletal Conference

KLISBio to disclose state-of-the-art tissue-engineered technology platform at 2022 CG Musculoskeletal Conference

KLISBio is focused on developing innovative solutions that solve prominent unmet clinical needs through a silk-based multidisciplinary technology platform able to generate products and solutions for a variety of clinical indications, such as peripheral nerve injuries, peripheral vascular diseases, bone defects, tendon tears and situations where a sustained drug ...

ByKLISBio


KLISBio to share innovative tissue-engineered technology at LSI 2022 Emerging MedTech Summit

KLISBio to share innovative tissue-engineered technology at LSI 2022 Emerging MedTech Summit

“KLISBio is focused on developing innovative solutions to tackle prominent unmet clinical needs through a silk-based multidisciplinary technology platform able to generate products and solutions for a variety of clinical indications, such as peripheral nerve injuries, peripheral vascular diseases, bone defects, tendon tears and situations where a sustained ...

ByKLISBio


KLISBio to share innovative tissue-engineered technology at BIO Partnering with JP Morgan

KLISBio to share innovative tissue-engineered technology at BIO Partnering with JP Morgan

KLISBio is focused on developing innovative solutions that solve prominent, unmet clinical needs through a silk-based multidisciplinary technology platform able to generate products and solutions for a variety of clinical indications, such as peripheral nerve injuries, peripheral vascular diseases, bone defects, tendon tears and situations where a sustained drug ...

ByKLISBio


Silk Biomaterials ushers in the next evolution of life sciences innovation with rebranding and new name

Silk Biomaterials ushers in the next evolution of life sciences innovation with rebranding and new name

KLISBio is focused on developing innovative biomedical solutions that solve prominent, unmet clinical needs through a silk-based multidisciplinary technology platform able to generate products and solutions for a variety of clinical indications, such as peripheral nerve injuries, peripheral vascular diseases, bone defects, tendon tears and situations where a ...

ByKLISBio


KLISBio to feature engineered silk innovation at AAHS 2022

KLISBio to feature engineered silk innovation at AAHS 2022

KLISBio is focused on healing and regenerating human body tissues by developing innovative solutions that solve prominent, unmet clinical needs through a silk-based multidisciplinary technology platform able to generate products and solutions for a variety of clinical indications, such as peripheral nerve injuries, peripheral vascular diseases, bone defects, ...

ByKLISBio


KLISBio to feature engineered silk innovation at Biotech Showcase

KLISBio to feature engineered silk innovation at Biotech Showcase

Engineered silk materials provide a unique combination of outstanding biological and mechanical properties for a variety of clinical indications such as peripheral nerve injuries, peripheral vascular diseases, bone defects, tendon tears and situations where a sustained drug release is needed. ...

ByKLISBio


Golden Valley Memorial Healthcare is First Hospital in Missouri to Perform Total Knee Replacement Procedures with THINK Surgical’s Next-Generation Robot System

Golden Valley Memorial Healthcare is First Hospital in Missouri to Perform Total Knee Replacement Procedures with THINK Surgical’s Next-Generation Robot System

“With the TSolution One system, not only is each surgery planned in advance, but a robot cuts the bone in the manner I specify, ensuring unmatched, precise placement of the implant,” said Dr. ...

ByThink Surgical Inc.


Healx pledges $25,000 to AKU Society patient registry campaign

Healx pledges $25,000 to AKU Society patient registry campaign

This campaign aims to develop and run a global patient registry for alkaptonuria – also known as AKU, or Black Bone Disease. AKU is an extremely rare genetic condition, affecting roughly one in 250,000 people around the world. It inhibits the breakdown of homogentisic acid in the body, which can cause significant damage to the bones, ...

ByHealx Ltd.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About XPRT Media

XPRT is a global industry marketplace and information resource. Online product catalogs, news, articles, events, publications & more.


  • FAQs
  • Company sitemap
  • Category sitemap
XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
Medical XPRT